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ABSTRAK
Dalam kurun waktu 11 tahun antara 1Januari 2005 sampai 31 Desember 20015 sebanyak 18 kasus PDA 
pada anak remaja dan dewasa dilakukan penutupan PDA dengan alat Amplatzer Duct Occluder (ADO). Terdapat 
9 kasus anak remaja yang berumur antara 14-18 tahun dan 9 orang dewasa yang berumur di atas 18 tahun 
dengan umur yang tertua 46 tahun. Sebelum pelaksanaan tindakan, dilakukan pemeriksaan klinis, EKG dan foto 
toraks serta ekokardiografi transtorakal untuk konfirmasi diagnostik PDA. Prosedur implantasi ADO dilakukan 
dengan anastesi umum pada remaja dan anestesi lokal dan sedasi pada pasien dewasa. Ukuran diameter PDA 
berkisar antara 1,6 mm-11,1 mm. Berdasarkan klasifikasi Kritchenko terdiri dari 15 PDA tipe A1 dan 3 kasus 
tipe A2. Flow rati oantara sirkulasi pulmonal dan sirkulasi sistemik berkisar antara 1,1–5,9. Waktu pelaksanaan 
prosedur berkisar antara 60-189 menit dengan waktu florsokopi antara 7,1-77,3 menit. Tekanan rata-rata pada 
arteri pulmonalis berkisar antara 22-63 mmHg dengan tekanan tertinggi sebesar 63 mmHg terdapat pada 2 
kasus (no 12 dan 13). Segera setelah prosedur tindakan menujukkan penutupan total pada 14 kasus dan pada 
4 kasus terdapat pirau residual minimal pada gambaran angiografi yang kemungkinan disebabkan kebocoron 
sementara melalui sela-sela device. Dalam 24 jam pertama setelah tindakan ditemukan penutupan total pada 
semua kasus (100%) dan hasil tersebut ditemukan sampai 1 bulan dan 6 bulan setelah tindakan. Selama kurun 
waktu tersebut tidak ditemukan sisa pirau (residual shunts) dan komplikasi berarti lainnya seperti embolisasi 
device atau rekanalisasi pada duktus.
Hasil studi seri kasus ini ini menunjukkan bahwa penutupan PDA dengan prosedur transkateter menggunakan 
ADO pada pasien remaja dan dewasa dalam jangka pendek sangat baik dan efektif serta tidak ada komplikasi 
yang berarti. Namundemikian masih diperlukan pemantauan jangka panjang untuk menilai efektivitas dan 
keamanan prosedur ini.
Kata kunci: penutupan transkateter, duktus arteriosus persisten, remaja, dewasa, Amplatzer duct occluder 
(ADO).
ABSTRACT
During 11 years period from January 2005 to December 2015 there were 18 adolescent and adult patients 
who underwent transcatheter closure of PDA using PDA Amplatzer Duct Occluder (ADO). There were 9 cases 
with age of 14 to 18 years and 9 cases with age of more than 18 years where the oldest case was 46 years old. 
Two cases were male and 16 cases were female. Prior to procedures, clinical assessment, ECG, chest x-ray and 
transthoracic echocardiography (TTE) were performed to confirm the diagnosis of PDA. The procedures of device 
implantation was performed under conscious sedation in adults and using general anesthesia in adolescents.
The size of PDA ranged from 1.6 mm to 11.1 mm. Based on Kritchenko classification, the type of PDA were 
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15 type A1 and 3type A2. Flow ratio between pulmonary to systemic circulation was between 1.1 and 5.9. The 
procedure time ranged from 60-189 minutes and the fluoroscopic time 7.1-77.3 minutes. The PA pressure ranged 
from 22 to 63 mmHg. Immediate results after procedures as seen in angiography showed complete closure in 
14 cases and smoky residual shunt or minimal residual shunts in 4 cases, which probably due to the temporary 
leaking through the devices. In 24 hours, complete closure was achieved in all cases (100%) and continued 
until 1months. At 6 month follow up, there was no residual shunts detected and also there was no significant 
complications, such as device embolization or recanalization. 
This case series suggest that transcatheter closure of PDA in adolescents and adults using Amplatzer duct 
occluder (ADO) is effective and has excellent resultswithout significant complication. However, long-term follow 
up is required to assess long term efficacy and safety.
Keywords: transcatheter closure, patent ductusarteriosus, adolescent, adult, Amplatzer duct occluder.
INTRODUCTION
Patent ductus arteriosus (PDA) is vascular 
structure that connects the left pulmonary artery 
near its origin to the descending aorta. This 
structure is important during fetal life and in full-
term infants, about 90% closes spontaneously the 
48 hours of life. PDA is considered a congenital 
heart defect if there is persistent patency beyond 
the third month of life in full term infants.1 In 
infants and children, PDA can be associated 
with various congenital heart disease like ASD 
or VSD, but in adults, it is usually an isolated 
lesion. The incidence of PDA is approximately 
1 per 2000 live birth, accounting for 5-10% of 
congenital heart diseases.2 Most of the PDA were 
detected and treated in infancy and childhood. 
However, in the developing world, some cases 
could be detected very late in the adolescence or 
even in adulthood due to the lack of resources 
and access to cardiac centers.
The clinical significance of PDA depends 
largely on the size and the underlying 
cardiovascular status and co-morbidities of 
the patient. The PDA may be “silent” with no 
evidence of clinical symptoms (asymptomatic). 
The silent PDA is detected incidentally by 
primary care physician during other examination, 
in which the echocardiography was done for 
different reasons. The anatomy of PDA in adults 
may differ from children due to calcification 
or aneurysm, which may cause challenges in 
performing transcatheter closure of PDA and, 
therefore, a surgery is required. However, it 
has been reported that transcatheter closure of 
the PDA in adults may be safe and effective 
but data is very limited.3 The mortality rate of 
untreated PDA in adults is 1.8% per year.4 There 
are also some additional complications, such as 
LV overload, pulmonary hypertension, infective 
endocarditis, calcification, aneurysm and rarely 
rupture.5 Here we presented a case series on the 
short-term results of transcatheter closure of PDA 
in 18 adolescents and adults which consists of 
complete closure and complications from the 
years of 2005 to 2015.
CASE ILLUSTRATION
During 11 years period from 2005 until 
2015, there were 18 of adolescents and adults 
undergoing transcatheter closure of PDA using 
ADO. There were 9 adolescents between 14 and 
18 years of age, while the remaining 9 patients 
were adults, among whom the oldest case was 
46 years old. Most of the patients were female 
(Table 1).
The size of PDA ranged from 1.6 mm to 
11.1 mm. Based on Kritchenko classification, 
the type of PDA were 14 of A1 type and 3 of 
A2 type. Flow ratio between pulmonary to 
systemic circulations ranged from 1.1 to 5.9. 
The procedure time was 60-189 minutes and 
the fluoroscopic time was 7.1-77.3 minutes. The 
range of PA pressure was 22-63 mmHg, in which 
the highest occurred in patient no. 12 and 13.
Transcatheter Closure of PDA Procedure
T h i s  c a s e  s t u d y  w a s  p e r f o r m e d 
retrospectively by reviewing the medical 
records of 18 adolescents and adults (2 male 
and 16 female) patients admitted between 2005 
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Table 1. Hemodynamic data and immediate results of transcatheter closue of PDA using ADO
Pts 
No.
Sex/
Age Year Device
W 
(Kg)
PDA 
size Type FR FT PT Comp.
Immediate 
result
PA 
sys
PA 
dias
PA 
mean
1 F/20 2006 ADO I 46.0 4.0 A1 3.2 7.1 71 nil complete closure 58 17 37
2 F/14 2007 ADO I 54.5 3.35 A2 1.1 12.8 68 nil complete closure 22 12 8
3 F/18 2008 ADO I 42.0 3.00 A1 2.2 43.3 125 nil complete closure 26 17 21
4 F/23 2008 ADO I 48.0 5.67 A1 1.8 9.3 60 nil smoky residual shunt 30 18 24
5 F/15 2009 ADO I 38.0 6.00 A2 2.9 33.6 170  nil smoky residual shunt 67 35 49
6 M/14 2009 ADO I 43.0 7.00 A1 4.9 17.0 80 nil complete closure 58 33 42
7 F/37 2010 ADO I 49.0 4.00 A1  3.0 38.3 120 nil complete closure 22 9 15
8 F/14 2010 ADO I 23.0 2.60 A2 3.5 13.6 150 nil smoky residual shunt 40 25 33
9 F/18 2012 ADO I 55.0 5,6. A1 1.2 22.1 133 nil complete closure 48 27 37
10 M/15 2012 ADO I 33.0 6.02 A1 5.9 19.4 69 nil complete closure 60 30 42
11 F/18 2012 ADO I 49.0 8.00 A1 1.9 17.1 68 nil complete closure 45 10 27
12 F/23 2012 ADO I 47.0 6.0.0  A1 2.5 14.0 70 nil smoky residual shunt 83 46 63
13 F/17 2013 ADO I 10.0 8.00 A1 3.2 17.8 120 nil complete closure 90 36 63
14 F/16 2013 ADO I 43.0 10.00 A1 2.3 11.0 60 nil complete closure 74 42 57
15 F/39 2013 ADO I 42.0 11.30 A1 1.4 77.3 189 nil complete closure 30 14 26
16 F/20 2015 ADO I 53.0 6.50 A1 2.5 8.1 70 nil complete closure 40 15 32
17 F/15 2014 ADO I 40.0 4.20 A1 2.0 12.0 60 nil complete closure 38 15 30
18 F/46 2014 ADO I 61.5 6.96 A1 1.4 22.2 99 nil
complete 
closure 61 32 49
W: Weight; FR: Flow Ratio; FT: Flouroscopy Time; PT: Procedure Time; PA: Pulmonary artery; Comp: complication.
and 2015 at Integrated Cardiovascular Center 
(PJT), Dr. Cipto Mangunkusumo Hospital 
Jakarta. Prior to the intervention procedures, 
clinical assessment, ECG, chest X-ray, and 
trans-thoracic echocardiography (TTE) were 
performed to confirm the diagnosis of PDA. 
The procedures of the device implantation were 
performed under conscious sedation in adults and 
with general anesthesia in adolescents. A single 
dose of intravenous antibiotic is administered 
(cephalosporin) 30 mg/kg BW (max 1 gram) 
30 minutes before the catheterization and 
two subsequent doses at 8 and 16 hours after 
the procedure. A 100 international unit (IU)/
kg (maximum 5000 IU) of sodium heparin 
were administered after insertion of catheter 
at the femoral artery. The right and left heart 
catheterization was performed and an aortogram 
with true lateral position was made to visualize 
the size and shape of the duct and to assess the 
minimum diameter, diameter of the aortic ampulla 
and the length of the duct (Figure 1). We used 
Amplatzer ductal occluder (ADO I ) device, in 
which the size chosed was at least 2 mm larger 
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than narrowest diameter of the duct. The device 
then was immersed into saline solution. After 
the device was screwed to the tip of the delivery 
cable, it was then loaded into the delivery catheter 
and the whole system is immersed into saline 
again (Figure 2). After this, the device was 
introduced and advanced through the sheath into 
the descending aorta by fluoroscopy guidance, 
and then the retention disk was deployed in the 
descending  aorta. The sheath and the retention 
disk were pulled back firmly into the ampulla of 
the duct. At this position the rest of device was 
deployed by holding the delivery cable of the 
device while pulling back the delivery sheath. 
To confirm the correct position of the device, 
an aortogram was performed soon afterward, to 
ensure the retention disk sitting on the rim of the 
ductal ampulla and not obstructing the descending 
aorta. The device could be replaced by another 
device of different size as necessary. If everything 
is correct and the position of the device is stable, 
the device can be released by rotating the delivery 
cable in the anticlockwise direction.
Device Profile
All of our patients had their PDA closed by 
ADO I. The ADO (AGA Medical Corporation, 
Golden Valley, MN) is a self-expanding and self-
centering device made from 0.0004 (0.1mm) to 
0.0005 inch nitinol wire mesh. It is mushroom-
shaped with a low profile and consist of a flat 
retention disk and a cylindrical main body, into 
which polyester fibers are sewn (Figure 1).
ADO has a retention disk which is 4 mm 
larger than the main body which itself has a 
conical structure. The delivery system consists 
of a delivery cable, a Mullin-type sheath, loader 
and a pin vise. The size of the device used will be 
at least 2 mm larger than the size the narrowest 
diameter of the duct.
At the end of the procedures, the arterial 
and venous catheter were removed and the 
compression of the groin was done to achieve 
the hemostasis. Follow up echocardiogram 
was performed 24 hour post-procedure. The 
aim of repeating the echo was to demonstrate 
the orientation of the device (its relation to 
descending aorta and the branches of pulmonary 
arteries, and to visualize the degree of residual 
shunting. A chest x-ray in anterior/posterior and 
lateral projections was done prior to discharge. 
Further clinical follow up and echocardiography 
were undertaken at 24 hours, 1 months, and 6 
months after the procedures.
Follow-up
The immediate results after procedures as 
shown by angiography were complete closure 
in 14 patients and smoky residual or minimal 
residual shunts in 4 patients,which was probably 
due to temporary leak through the device.
At 24 hour follow up after the procedure, 
complete closure was achieved in all patients 
and persisted at 1 month follow up. The follow 
up after 6 months, there was no residual shunt 
detected and no significant complications 
occured, such as device embolization or 
recanalization.
DISCUSSION
Transcatheter closure of PDA has been 
performed worldwide since the first percutaneous 
closure of PDA by Porstman in 1967.6 There were 
Figure 1. Amplatzer duct occluder (ADO)
Figure 2. Angiography before and after implantation of ADO 
(before released)
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various kind of duct occluder available, such as 
Rashkind occluder, Gianturco coils, Lifetech 
device, and ADO as the most commonly used 
device. The ADO is  an expandable device that 
has been used in many centers with excellent 
results since early 2000. Bilkis et.al reported 
the safety and efficacy of closing the PDA using 
ADO in 209 patients, particularly in symptomatic 
infants and small children with relatively large 
PDA.3 Most PDA are closed during infancy or 
childhood, when there were significant clinical 
symptoms and signs, which causes hemodynamic 
disturbances with left atrial and ventricle volume 
overload and pulmonary hypertension. Djer MM 
et.al reported good results of PDA closure using 
devices, mostly with ADO, with success rate of 
97.3% in the period of 11 years.7
In adults, PDA is usually “silent” with no 
clinical symptoms or asymptomatic, which is 
detected incidentally during routine physical 
examination or echocardiography for other 
purposes. Therefore, the treatment of PDA in 
adults remains controversial.5 PDA closure 
by surgical intervention has been the “gold 
standard” since 1939, especially for a large 
PDA.8,9 However, in adults, surgical closure 
has some challenges and difficulties due to 
duct calcification, aneurysm, and other related 
comorbidities such as coronary atherosclerosis 
and renal diseases. Therefore, transcatheter 
closure of PDA in adults and adolescents is an 
alternative to surgery with good results. Wilson 
et.al (1993) reported effective results of PDA 
closure in adults and children.10Hong et al 
(2002) reported 36 out of 37 patients (97%) had 
successful ADO placement.11
In our study of 18 patients, 9 were adolescents 
and 9 were adults; all of them had succesful ADO 
placement. Immediately after the procedures, 
complete closure was achieved in 14 of 18 
patients, whereas the remaining four had minimal 
or “smoky” residual shunts. However, all of the 
patients had complete closure after 1 month and 6 
months. There were no residual shunts at 6 month 
follow up. Mean pulmonary artery pressure 
increased in 7 of 18 patients, of whom all were 
adults. The PA pressure ranged between 42–63 
mmHg was reversible to the administration 
of 100% oxygen with good results after PDA 
closure. Transcatheter closure of PDA in adults 
with severe pulmonary artery hypertension 
seemed to be feasible, effective and safe as 
reported previously.13
In general, PDA transcatheter closure has been 
proven to be effective with excellent results, but 
there were several reported complications, such 
as embolization, narrowing of LPA, or aortic 
obstruction.12 In general, the complications of 
transcatheter closure of PDA is very low both in 
children and adult patients.14 The occurrence of 
embolization rate varies from 0% and 3.1%.12,15 
In our study, no device embolization occurred 
at all, which was probably related to careful 
case and device selections. There was no other 
complications observed in this study and the 
overall succesful rate was high. A previous study 
reported an overall success rate of 98.1% among 
69 adults undergoing percutaneous PDA closure.16
CONCLUSION
Our study showed that transcatheter closure 
of PDA in adolescents and adults is effective 
and safe with excellent results in short-term 
follow up. No serious complications such as 
endocarditis ordevice embolization in the 6 
month follow up. However, a long-term follow 
up is needed.
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